Fruquintinib With or Without HAI-FOLFOX for Refractory Colorectal Cancer

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

May 24, 2024

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2029

Conditions
Colorectal Cancer
Interventions
DRUG

Fruquintinib

A treatment cycle of 4 weeks, with 5 mg orally once daily for 3 weeks, followed by a 1-week break

DRUG

Fluorouracil

2.8 g/m² (400mg bolus + 2.4g/m² continuous infusion) given every 2 weeks through hepatic arterial infusion

DRUG

Oxaliplatin

85 mg/m² given every 2 weeks through hepatic arterial infusion

Trial Locations (1)

510060

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER